irinotecan stada 20 mg/ml
cell pharm gmbh - germania - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice
irinotesin 20mg/ml
sindan s.r.l. - romania - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice
voraxaze
serb sas - glucarpidase - metabolic side effects of drugs and substances - toate celelalte produse terapeutice - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.
irinotecan hospira 20mg/ml
hospira uk limited - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice
irinotecan accord 20 mg/ml
accord healthcare polska sp. z.o.o. - polonia - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alcaloizi din plante si alte produse naturale inhibitori citostatici ai topoizomerazei i
oxaliplatin accord 5 mg/ml
accord healthcare polska sp. z.o.o. - polonia - oxaliplatinum - conc. pt. sol. perf. - 5mg/ml - alte antineoplazice compusi de platina
irinotecan sun 1,5 mg/ml
sun pharmaceutical industries europe b.v. - olanda - irinotecanum - sol. perf. - 1,5mg/ml - alcaloizi din plante si alte produse naturale inhibitori citostatici ai topoizomerazei i
oxaliplatin accord 5 mg ml 50 mg/10 ml concentrat pentru soluţie perfuzabilă
accord healthcare polska sp. z o.o. - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 50 mg/10 ml
oxaliplatin accord 5 mg ml 100 mg/20 ml concentrat pentru soluţie perfuzabilă
accord healthcare polska sp. z o.o. - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 100 mg/20 ml
oxaliplatin 5 mg/ml concentrat pentru soluţie perfuzabilă
seacross pharmaceuticals limited - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 5 mg/ml